USD10
NRIX Shares
About Nurix TherapeuticsNurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

USD10
NRIX Shares
About Nurix TherapeuticsNurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Stats

TRADING WINDOW

Closed

OPENS AT

Mar 20 at 1:30 PM GMT+0

MARKET CAP

$1.48B

OPEN PRICE

$14.92

LOW (1Y)

$8.18

HIGH (1Y)

$22.50

LOW (24H)

$14.42

HIGH (24H)

$15.48

VOLUME (24H)

$5.44M

352.28%

Price history

Time
Price
Change
Today
$14.92
3.28%
1 Day
$14.92
3.28%
1 Week
$15.10
4.44%
1 Month
$15.78
8.56%
1 Year
$12.99
11.09%
Past performance is not a reliable indicator of future results.

Discover more

Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.